PHARMACEUTICAL COMPOSITION FOR ANTICANCER INCLUDING NOVEL HYDROXAMIC ACID WITH HISTONE DEACETYLASE INHIBITING ACTIVITY AS ACTIVE INGREDIENT

摘要

The present invention relates to a pharmaceutical composition for anticancer including novel hydroxamic acid with histone deacetylase inhibiting activity as an active ingredient. Hydroxamic acid compound of the present invention has inhibitory activity of histone deacetylase (HDAC) and shows cytotoxicity to a variety of cancer cells, being useful in strong anti-cancer drug.;COPYRIGHT KIPO 2014